Učitavanje...
Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer
BACKGROUND: Acquired drug resistance to the chemotherapeutic drug irinotecan (the active metabolite of which is SN-38) is one of the significant obstacles in the treatment of advanced colorectal cancer (CRC). The molecular mechanism or targets mediating irinotecan resistance are still unclear. It is...
Spremljeno u:
| Izdano u: | PLoS One |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Public Library of Science
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5531462/ https://ncbi.nlm.nih.gov/pubmed/28749961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0180616 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|